Technology | Treatment Planning | August 15, 2017

French company achieves CE Mark for treatment planning system for modeling and computing dose distributions with double scattering beams and pencil beam scanning

DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System

August 15, 2017 — DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for proton therapy with active scanning beams (pencil beam scanning). The milestone was achieved through close collaboration with Institut Curie - Protontherapy Center of Orsay (ICPO) in France.

Due to the high energy of proton beams and specific dose deposit phenomena, proton therapy planning requires particular dose computation accuracy for dealing with uncertainties, according to the dose delivery technique.

ISOgray-Proton software is now available for modeling and computing dose distributions with double scattering beams and pencil beam scanning (PBS) technologies of IBA proton radiotherapy treatment machines.

The latest development offers new features such as:

  • Single Field Uniform Dose (SFUD) optimization to deliver a uniform dose per field in a target volume; and
  • Exacor module used to carry out PBS verification plans as well as to compare the results obtained with measurements from various detectors (e.g., IBA-MatriXX).

Robust optimization algorithms based on the Pencil Beam Kernel dose calculation model are available with user-friendly interface to offer highly conformal treatments. 

In the context of a modernization project of its center begun in 2010, ICPO near Paris, France and DOSIsoft have been collaborating actively since then for new algorithm implementation and joint research activities.

“As the first center in France to implement ISOgray-Proton, ICPO confirms the promising results from the partnership. This proton therapy planning technology offers new modalities to facilitate the treatment of tumors situated near important organs and structures like cranial base tumors.” commented Ludovic De Marzi, medical physicist at ICPO.

Read the related article "Imaging Considerations for Proton Therapy Treatment Planning."
 

 

For more information: www.dosisoft.com


Related Content

News | Radiation Therapy

May 16, 2024 — Today marks a significant milestone in cancer care with the introduction of bipartisan federal ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | Radiation Therapy

May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...

Time May 01, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
Subscribe Now